The Laboratory for Innovation in Breast Cancer transforms cutting-edge research into better outcomes for patients. Our multidisciplinary team - radiation oncologists, surgical oncologists, medical oncologists, biostatisticians, geneticists, and clinical researchers - collaborates to bridge the gap between scientific discovery and patient care. We combine deep clinical expertise with rigorous scientific investigation, conducting both translational research and clinical trials to advance cancer care. This integrated approach allows us to rapidly translate promising findings into novel treatment options for our patients.

Our research focus centers on precision radiation therapy, investigating how genetic factors influence treatment response, and developing combination therapies that maximize cancer control while minimizing side effects. We study treatment approaches for all stages of breast cancer—from early-stage disease to recurrent and metastatic cancers—always with the goal of improving both survival and quality of life.

Impact in practice: Our findings directly inform treatment protocols at Memorial Sloan Kettering and influence breast cancer care worldwide. By designing and conducting clinical trials, we help determine which patients benefit most from specific radiation techniques and identify new therapeutic combinations that offer hope to patients facing challenging diagnoses.

Our commitment extends beyond research to education and advocacy, ensuring that scientific advances reach the patients who need them most.